Madrigal Pharmaceuticals, Inc.
MDGL
$301.66
-$6.12-1.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 926.25M | 998.63M | 1.06B | 1.06B | 634.13M |
| Total Receivables | 53.82M | 30.46M | 6.90M | -- | -- |
| Inventory | 34.07M | 8.72M | 7.07M | 854.00K | -- |
| Prepaid Expenses | 13.79M | 20.86M | 14.96M | 14.04M | 3.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.00M | 5.00M | 5.00M | -- | -- |
| Total Current Assets | 1.03B | 1.06B | 1.09B | 1.07B | 637.28M |
|
|
|||||
| Total Current Assets | 1.03B | 1.06B | 1.09B | 1.07B | 637.28M |
| Net Property, Plant & Equipment | 4.59M | 4.78M | 3.15M | 3.33M | 3.27M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.73M | 4.82M | 4.91M | 5.00M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.04B | 1.07B | 1.10B | 1.08B | 640.55M |
|
|
|||||
| Total Accounts Payable | 43.60M | 45.97M | 8.99M | 21.53M | 28.04M |
| Total Accrued Expenses | 124.70M | 131.00M | 115.61M | 92.27M | 89.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 983.00K | 878.00K | 557.00K | 542.00K | 527.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 169.28M | 177.85M | 125.16M | 114.34M | 118.55M |
|
|
|||||
| Total Current Liabilities | 169.28M | 177.85M | 125.16M | 114.34M | 118.55M |
| Long-Term Debt | 117.57M | 117.09M | 116.61M | 116.14M | 115.48M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.02M | 1.18M | 900.00K | 1.05M | 1.19M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 287.86M | 296.11M | 242.67M | 231.52M | 235.21M |
|
|
|||||
| Common Stock & APIC | 2.56B | 2.52B | 2.49B | 2.33B | 1.74B |
| Retained Earnings | -1.80B | -1.74B | -1.64B | -1.48B | -1.34B |
| Treasury Stock & Other | 468.00K | 1.27M | -368.00K | -172.00K | 468.00K |
| Total Common Equity | 754.38M | 777.16M | 857.12M | 850.76M | 405.33M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 754.38M | 777.16M | 857.12M | 850.76M | 405.33M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 754.38M | 777.16M | 857.12M | 850.76M | 405.33M |
|
|
|||||